ATLANTA--(BUSINESS WIRE)--Sciele Pharma, Inc. (NASDAQ:SCRX - News), a specialty pharmaceutical company, today announced increased revenues and earnings for the third quarter and nine months ended September 30, 2007. Net revenues for the third quarter of 2007 increased 33% to $99.4 million from $74.8 million in the third quarter of 2006. Diluted earnings per share (EPS) for the third quarter of 2007 increased 12% to $0.38 compared with $0.34 in the third quarter of 2006.
